TVM Capital Life Science β Full Portfolio
5 tracked investments Β· listed companies and verified rows first
Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications.
BiotechHealthtechMedical DevicesNew MaterialsBedford, US
James Biggins(Chief Executive Officer, President and Founder)inDennis Byrne(Chief Commercial Officer)inScott Blood(VP of Regulatory and Quality)inKatie Motherway(VP of Human Resources)inPaul Sabin(Director)Joseph Pellegrino(Director)
Co-investorsGreen Park & Golf VenturesTVM Capital
Egg Medical develops the EggNest, a scatter radiation shielding system designed to reduce radiation exposure for interventional fluoroscopy teams during cardiac catheterization and endovascular procedures.
HardwareHealthtechMedical DevicesArden Hills, US
Robert F. Wilson(Founder & Chief Executive Officer)inJohn Gainor(Co-founder & Chief Technology Officer)inScott Youngstrom(Chief Financial Officer)inGavin Philipps(Chief Commercial Officer)in
BoardMarc Riviere(Director)Luc Marengere(Director)
Co-investorsJStar Capital InvestmentsTVM Capital
Emovi Inc commercializes KneeKG, a regulatory-cleared clinical assessment tool that measures knee movement patterns to evaluate functional deficiencies and aid in orthopaedic decision-making for pain management and surgical planning.
AI & Machine LearningDigital HealthHealthtechMedical DevicesLaval, CA
BoardGuy Grimard(MD, FRCSC)Pierre Ranger(MD)Patrick Lavigne(MD, PhD, FRCSC)David Baillargeon(MD, CM, FRCSC)
Co-investorsBoston Harbor AngelsDesjardins CapitalStandUp Ventures
Vektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias.
AI & Machine LearningDigital HealthHealthtechMedical DevicesCarlsbad, US
Chris Villongco(Head of Technology / CTO)inRob Krummen(CEO (formerly President & COO))inKelly Perez(Head of Finance)inAlexander Michael Monko(Executive Officer, Director)
Co-investorsSolas BioVentures
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.